369 related articles for article (PubMed ID: 28749559)
1. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model.
Li G; Zhu Y; Shao D; Chang H; Zhang X; Zhou D; Gao Y; Lan K; Deng Q
Hepatology; 2018 Jan; 67(1):56-70. PubMed ID: 28749559
[TBL] [Abstract][Full Text] [Related]
2. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
[TBL] [Abstract][Full Text] [Related]
3. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia.
Wu M; Wang C; Shi B; Fang Z; Qin B; Zhou X; Zhang X; Yuan Z
Antiviral Res; 2020 Aug; 180():104826. PubMed ID: 32502604
[TBL] [Abstract][Full Text] [Related]
4. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
6. A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus.
Zhou Z; Li C; Tan Z; Sun G; Peng B; Ren T; He J; Wang Y; Sun Y; Wang F; Li W
Antiviral Res; 2023 Aug; 216():105642. PubMed ID: 37253400
[TBL] [Abstract][Full Text] [Related]
7. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
Guo X; Chen P; Hou X; Xu W; Wang D; Wang TY; Zhang L; Zheng G; Gao ZL; He CY; Zhou B; Chen ZY
Sci Rep; 2016 May; 6():25552. PubMed ID: 27174254
[TBL] [Abstract][Full Text] [Related]
8. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
[TBL] [Abstract][Full Text] [Related]
10. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
[TBL] [Abstract][Full Text] [Related]
11. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.
Kruse RL; Legras X; Barzi M
Virus Res; 2021 Jan; 292():198224. PubMed ID: 33166564
[TBL] [Abstract][Full Text] [Related]
12. Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System.
Ding J; Yi Z; Zai W; Wu M; Chen B; Cai Q; Zhang X; Yuan Z
mBio; 2023 Apr; 14(2):e0355022. PubMed ID: 36840581
[TBL] [Abstract][Full Text] [Related]
13. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
[TBL] [Abstract][Full Text] [Related]
15. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
Cui X; Guo JT; Hu J
J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
[TBL] [Abstract][Full Text] [Related]
18. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
[TBL] [Abstract][Full Text] [Related]
19. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
[TBL] [Abstract][Full Text] [Related]
20. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
Schreiner S; Nassal M
Viruses; 2017 May; 9(5):. PubMed ID: 28531167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]